Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts Inc (NQ: TMCI )

24.75 +0.67 (+2.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 288,331
Open 24.00
Bid (Size) 9.910 (1)
Ask (Size) 26.18 (2)
Prev. Close 24.08
Today's Range 23.92 - 24.80
52wk Range 12.48 - 26.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Treace Medical Concepts' Shares Rose Wednesday
The company's Lapiplasty surgery kits are driving increased revenue. 
Via The Motley Fool
Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million. 
Via Benzinga

Performance

YTD
+10.54%
+10.54%
1 Month
+13.07%
+13.07%
3 Month
+6.36%
+6.36%
6 Month
+11.64%
+11.64%
1 Year
+29.92%
+29.92%

More News

Read More
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
A Preview Of Treace Medical Concepts's Earnings
Via Benzinga
Mesoblast, Arlo Technologies, CPI Card Group And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Treace Medical Concepts Reports Fourth Quarter and Full Year 2022 Financial Results
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Treace Medical Announces Settlement of Lawsuit Again Fusion Orthopedics
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Treace to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Treace Presents Updated ALIGN3D™ Interim Data and Latest Product Innovations at the 2023 ACFAS Annual Conference
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Why Treace Medical Concepts Stock Is Trading Lower
Via Benzinga
Treace Medical Concepts, Inc. Announces Pricing of $100.0 Million Public Offering of Common Stock
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Why Treace Medical Concepts (TMCI) Shares Are Falling During Tuesday's After-Hours Session
Via Benzinga
Treace Medical Concepts, Inc. Announces Proposed Public Offering of Common Stock
From Treace Medical Concepts, Inc.
Via Globe NewsWire
NASDAQ:TMCI Shareholder Alert: Investigation over Potential Wrongdoing at Treace Medical Concepts, Inc.
Via SBWire
Treace Medical Concepts Provides 2022 Preliminary Unaudited Revenue
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Bragar Eagel & Squire, P.C. Is Investigating BRP, Alico, Treace, and Welltower and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via Globe NewsWire
Treace to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023
From Treace Medical Concepts, Inc.
Via Globe NewsWire
Treace Medical Announces Expansion of Its Global IP Portfolio with the Grant of Two New U.S. Patents
From Treace Medical Concepts, Inc.
Via Globe NewsWire
NASDAQ:TMCI Investor Notice: Investigation over Possible Securities Laws Violations by Treace Medical Concepts, Inc.
Via SBWire
Treace Receives FDA 510(k) Clearance for SpeedPlate™ Rapid Compression Implant Technology
From Treace Medical Concepts, Inc.
Via Globe NewsWire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Treace Medical Concepts, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Treace Announces First Patient Treated in MTA3D™ Adductoplasty® Clinical Study
From Treace Medical Concepts, Inc.
Via Globe NewsWire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Treace Medical Concepts, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.